Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 U.S.C. 360l Postmarket surveillance
21 U.S.C. 360l Postmarket surveillance, “Postmarket surveillance”, is a U.S. Code section of Part A—Drugs and Devices; in force.
https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-389751edcbcb
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 U.S.C. 360l |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Postmarket surveillanceen |
| schema:url | |
| skos:prefLabel | 21 U.S.C. 360l Postmarket surveillanceen |
Related
Rules made under it (36)eli:based_on
- 21 CFR Part 1000—General
- 21 CFR Part 1002—Records and reports
- 21 CFR Part 1003—Notification of defects or failure to comply
- 21 CFR Part 1004—Repurchase, repairs, or replacement of electronic products
- 21 CFR Part 1010—Performance standards for electronic products: General
- 21 CFR Part 1020—Performance standards for ionizing radiation emitting products
- 21 CFR Part 1030—Performance standards for microwave and radio frequency emitting products
- 21 CFR Part 1040—Performance standards for light-emitting products
- 21 CFR Part 201—Labeling
- 21 CFR Part 26—Mutual recognition of pharmaceutical good manufacturing practice reports, medical device quality system audit reports, and certain medical device product evaluation reports: United States and the European Community
- 21 CFR Part 310—New drugs
- 21 CFR Part 3—Product jurisdiction
- 21 CFR Part 4—Regulation of combination products
- 21 CFR Part 56—Institutional Review Boards
- 21 CFR Part 812—Investigational device exemptions
- 21 CFR Part 820 #2—Quality system regulation
- 21 CFR Part 820—Quality system regulation
- 21 CFR Part 822—Postmarket surveillance
- 21 CFR Part 861—Procedures for performance standards development
- 21 CFR Part 862—Clinical chemistry and clinical toxicology devices
- 21 CFR Part 864—Hematology and pathology devices
- 21 CFR Part 866—Immunology and microbiology devices
- 21 CFR Part 868—Anesthesiology devices
- 21 CFR Part 870—Cardiovascular devices
- 21 CFR Part 872—Dental devices
- 21 CFR Part 874—Ear, nose, and throat devices
- 21 CFR Part 876—Gastroenterology-urology devices
- 21 CFR Part 878—General and plastic surgery devices
- 21 CFR Part 880—General hospital and personal use devices
- 21 CFR Part 882—Neurological devices
6 more
Cited by (9)eli:cites
- 21 CFR 1000.3 Definitions.
- 21 CFR 820.1 Scope.
- 21 CFR 820.250 Statistical techniques.
- 21 U.S.C. 331 Prohibited acts
- 21 U.S.C. 352 Misbranded drugs and devices
- 21 U.S.C. 360e-3 Breakthrough devices
- 21 U.S.C. 360i Records and reports on devices
- 42 CFR 11.10 What definitions apply to this part?
- 42 U.S.C. 282 Director of National Institutes of Health